Clinical evaluation of droplet digital PCR in suspected invasive pulmonary aspergillosis

Yang Liu1, Qiuping Tang1, Sishi Tang1

  • 1Department of Laboratory Medicine, West China Hospital, Sichuan University, Chengdu, Sichuan 610041, PR China.

Insights

A new droplet digital PCR (ddPCR) assay shows promise for diagnosing invasive pulmonary aspergillosis (IPA). This method offers improved sensitivity and specificity using bronchoalveolar lavage fluid, aiding in patient prognosis.

Area of Science:

  • Medical Diagnostics
  • Mycology
  • Molecular Biology

Background:

  • Invasive pulmonary aspergillosis (IPA) is a serious fungal infection with high mortality.
  • Current diagnostic methods for IPA lack sufficient sensitivity and specificity, complicating patient management.
  • There is a critical need for accurate and timely diagnostic tools for IPA.

Purpose of the Study:

  • To evaluate the diagnostic performance of a droplet digital PCR (ddPCR) assay for Aspergillus spp. in patients suspected of IPA.
  • To compare the sensitivity and specificity of the ddPCR assay with traditional methods like fungal culture and smear tests.
  • To assess the correlation between ddPCR results and patient prognosis.

Main Methods:

  • 163 patients with suspected IPA were enrolled, with data from 158 analyzed.
  • Cell-free DNA (cfDNA) from bronchoalveolar lavage fluid (BALF) or plasma samples was detected using a ddPCR assay targeting Aspergillus spp.
  • Patients were classified into IPA and non-IPA groups based on clinical data.

Main Results:

  • The ddPCR assay demonstrated a higher overall sensitivity (50.8%) for IPA diagnosis compared to fungal culture (44.3%) and smear tests (10.7%).
  • Sensitivity was significantly higher when using BALF samples (73.1% in IPA group, 88.2% in putative IPA subgroup) versus plasma samples (P < 0.01).
  • The assay achieved a high specificity of 94.4% and ddPCR results correlated with patient prognosis (P < 0.05).

Conclusions:

  • The ddPCR assay shows strong performance for IPA diagnosis, particularly with BALF samples, and is especially effective for detecting putative IPA.
  • This molecular diagnostic approach offers improved accuracy over conventional methods.
  • Integrating ddPCR results with clinical data can enhance prognostic predictions for IPA patients.